Open kokyriakidis opened 5 years ago
Hi,
Sorry, I did not notice this question before, so I'm only replying now.
Sarek was at the beginning designed to analyse tumor/normal pairs (and additional relapses), but we realised that it could work with just normal samples as well.
Sarek
was at the beginning a WGS analysis project, and we're still adding possibilities for analysing WES and targeted sequencing.
This nf-core/exoseq
pipeline was designed since the beginning to analyse Exome data, so it's definitively less complicated, and it obviously doesn't work on WGS.
I also think that the development is on hold at the moment.
That pretty much sums it up for the moment 👍
Note that there were some thoughts to make this work at least for exomes, but Sarek covers much of this use case so we put a hold on it...
What is the difference between this and Sarek pipeline?